Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement in lung disease.

Vidya J Sarma1, Markus Huber-Lang, Peter A Ward

  • 1Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.

Autoimmunity
|August 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes of Intestinal Aquaporins after Experimental Polytrauma and Hemorrhagic Shock: Erratum.

Shock (Augusta, Ga.)·2026
Same author

Extracellular Vesicle and Plasma miRNAs as Candidate Biomarkers of Traumatic Brain Injury in the Context of Polytrauma.

International journal of molecular sciences·2026
Same author

The Cellular Response Capacity as Diagnostic Head Start in Neutrophil Endotoxemia Sensing.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Microbial Legacy: Mycobacterium vaccae ATCC 15483<sup>T</sup> intergenerationally diversifies the microbiome and enhances stress resilience in male mice.

Molecular psychiatry·2026
Same author

A host defense role for Fibrinogen by direct binding of Clostridium botulinum C2 toxin.

Cellular and molecular life sciences : CMLS·2026
Same author

Production and characterization of gigastasin, a leech-derived inhibitor of complement and coagulation pathways.

Scientific reports·2026
Same journal

CCDC77 and SLC45A3 mediate the genetic mechanism of Hashimoto's thyroiditis through IL-6.

Autoimmunity·2026
Same journal

Multi-cohort transcriptomic analysis with machine learning identifies interferon-related candidate genes in systemic lupus erythematosus.

Autoimmunity·2026
Same journal

IgA Vasculitis with necrotizing arteritis: a multicenter retrospective study from the French Vasculitis Study Group and systematic review of the literature.

Autoimmunity·2026
Same journal

Global research trends in ferroptosis in autoimmune diseases: a bibliometric and visual analysis (2018-2025).

Autoimmunity·2026
Same journal

Monocyte exhaustion associated with systemic lupus erythematosus.

Autoimmunity·2026
Same journal

Statement of Retraction: Long non-coding RNA LINC00265 promotes proliferation, apoptosis, and inflammation of chondrocytes in osteoarthritis by sponging miR-101-3p.

Autoimmunity·2026
See all related articles

Complement proteins are key to immune responses. Their activation causes inflammation and cell damage, contributing to lung diseases like asthma and acute respiratory distress syndrome.

Area of Science:

  • Immunology
  • Pathophysiology
  • Respiratory Medicine

Background:

  • Complement proteins are crucial for innate and adaptive immunity.
  • Complement activation generates anaphylatoxins (C3a, C5a) and the membrane attack complex (C5b-9).
  • These mediators orchestrate inflammatory responses including cell recruitment and cytokine release.

Purpose of the Study:

  • To review recent findings on the role of complement in lung disease pathophysiology.
  • To highlight the involvement of complement activation in inflammatory lung conditions.

Main Methods:

  • Review of recent animal models and clinical data.
  • Analysis of the molecular mechanisms of complement activation in inflammation.

Main Results:

Related Experiment Videos

  • Complement activation drives key inflammatory events in the lungs.
  • Evidence links complement-mediated pathways to asthma and ARDS pathogenesis.
  • Specific complement components and their products are implicated in disease severity.

Conclusions:

  • The complement system is a significant contributor to lung disease development.
  • Targeting complement pathways may offer therapeutic strategies for respiratory diseases.
  • Further research is warranted to fully elucidate complement's role in lung pathology.